Our mission is to revolutionize drug development in order to create better therapies for patients. Medicines today are often toxic and unselective, working only for a small percentage of patients and leaving behind a trail of negative side effects. We aspire to change this paradigm and are developing highly selective, targeted medicines, that address known mutations in patients that have been pre-identified to respond effectively to our therapies.
We leverage our in-house drug design and operational expertise to create novel, irreversible small molecules against genetically defined forms of cancer. We then move these candidates swiftly through the development process to pursue our goal of delivering highly impactful medicines for patients in need.